Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Hall

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Health Technology Assessment (Winchester, England)|October 14, 2024
Vein bypass first vs. best endovascular treatment first revascularisation strategy for chronic limb-threatening ischaemia due to infra-popliteal disease: the BASIL-2 RCTCatherine A Moakes, Andrew W Bradbury, Zainab Abdali, et al.
Lancet (London, England)|April 28, 2023
A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trialAndrew W Bradbury, Catherine A Moakes, Matthew Popplewell, et al.
Trials|September 9, 2025
Who is in your trial? Improving the reporting of participant characteristics in trial protocols and resultsShaun Treweek, Shoba Dawson, Kamlesh Khunti, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Health Technology Assessment (Winchester, England)|October 14, 2024
Vein bypass first vs. best endovascular treatment first revascularisation strategy for chronic limb-threatening ischaemia due to infra-popliteal disease: the BASIL-2 RCTCatherine A Moakes, Andrew W Bradbury, Zainab Abdali, et al.
Lancet (London, England)|April 28, 2023
A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trialAndrew W Bradbury, Catherine A Moakes, Matthew Popplewell, et al.
Trials|September 9, 2025
Who is in your trial? Improving the reporting of participant characteristics in trial protocols and resultsShaun Treweek, Shoba Dawson, Kamlesh Khunti, et al.
Pageof 2